Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 09-1995 | 06-1995 | |
| Gross Profit | 1,612 | 587 | 419 | 616 | 870 |
| Operating Expenses | 757 | 701 | 745 | 869 | 782 |
| Operating Income | -757 | -701 | -745 | -869 | -782 |
| Pre-tax Income | -757 | -701 | -745 | -869 | -782 |
| Net Income Continuous | -757 | -701 | -745 | -869 | -782 |
| Net Income | $-757 | $-701 | $-745 | $-869 | $-782 |
| EBITDA(a) | $-757 | $-701 | $-745 | $-869 | $-782 |